Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Shares Issued (2021 - 2025)

Senti Biosciences has reported Shares Issued over the past 5 years, most recently at -$2.5 million for Q4 2025.

  • Quarterly results put Shares Issued at -$2.5 million for Q4 2025, down 105.62% from a year ago — trailing twelve months through Sep 2025 was $47.3 million (up 2131.06% YoY), and the annual figure for FY2024 was $47.3 million, changed.
  • Shares Issued for Q4 2025 was -$2.5 million at Senti Biosciences, down from $1.0 million in the prior quarter.
  • Over the last five years, Shares Issued for SNTI hit a ceiling of $225.4 million in Q4 2021 and a floor of -$2.5 million in Q4 2025.
  • Median Shares Issued over the past 5 years was $1.0 million (2025), compared with a mean of $22.1 million.
  • Biggest five-year swings in Shares Issued: crashed 248.79% in 2023 and later skyrocketed 14652.92% in 2024.
  • Senti Biosciences' Shares Issued stood at $225.4 million in 2021, then tumbled by 99.91% to $207000.0 in 2022, then crashed by 248.79% to -$308000.0 in 2023, then skyrocketed by 14652.92% to $44.8 million in 2024, then plummeted by 105.62% to -$2.5 million in 2025.
  • The last three reported values for Shares Issued were -$2.5 million (Q4 2025), $1.0 million (Q2 2025), and $1.5 million (Q1 2025) per Business Quant data.